Acorda Therapeutics, Inc

ACOR NASDAQ
ACOR
Acorda Therapeutics, Inc NASDAQ
 
Kommande intäkter
Utdelning per andel
Börsvärde
Utdelning
P/E-tal
Kommande intäkter
Utdelning per andel
Börsvärde
Utdelning
P/E-tal

ACOR financial statements

Acorda Therapeutics, Inc financial statements, including revenue, expenses, profit, and loss

The total revenue of ACOR for the last quarter is 31.46M USD, and it's 1.04% lower compared to the previous quarter. The net income of Q3 21 is -27.07M USD.

TTM
Bruttovinst
Totala intäkter
Cost of goods sold
Operating expenses (excl. COGS)
Rörelseintäkt
Non-operating income, total
Pretax income
Equity in earnings
Taxes
Non-controlling/minority interest
After tax other income/expense
Net income before discontinued operations
Discontinued operations
Nettoinkomst
Dilution adjustment
Preferred dividends
Diluted net income available to common stockholders
Basic earnings per share (Basic EPS)
Diluted earnings per share (Diluted EPS)
Average basic shares outstanding
Diluted shares outstanding
EBITDA
EBIT
Totala rörelsekostnader